Therapeutic Solutions International Inc (TSOI)

[centsability4me]

TSOI DD/Share Structure

TSOI products = 12 - 5 Biologics, 6 Nutraceuticals, 1 Pharmaceutical

6 TSOI nutraceutical products released from granted patent
Projuvenol, NanoStilbene, DermalStilbene, IsoStilbene, NeuroStilbene, Alpha Lipoic Acid
https://patents.google.com/patent/US9682047B2/en

4 TSOI nutraceutical products for sale online
Projuvenol, Nanostilbene, DermalStilbene, NeuroStilbene
http://www.youcanordernow.com/

5 Biologics, 1 Pharmaceutical licensed to Pan Am Cancer Treatment Center in Mexico
StemVacs, Cancer Metabolic DeTox, innaMune, LymphoBoost, MemoryMune, BRS-001
http://ih.advfn.com/p.php?pid=nmona&article=77606645
http://ih.advfn.com/p.php?pid=nmona&article=77309980
http://ih.advfn.com/p.php?pid=nmona&article=77635806

Pan Am Cancer Treatment Center Introductory Video

StemVacs Phase 1 clinical trials @ Pan Am Cancer Treatment Center in Mexico
Announced 5/1/18
http://ih.advfn.com/p.php?pid=nmona&article=77309980
for TSOI Right To Try Clinic future opening in USA .
https://ih.advfn.com/p.php?pid=nmona&article=77684969
Completed 9/4/18
Results :
https://ih.advfn.com/p.php?pid=nmona&article=78186786

Wes Chandler to Lead on CTE 8/22/18
https://ih.advfn.com/p.php?pid=nmona&article=78119448
Therapeutic Solutions International Recruits NFL Chargers Hall of Famer Wes Chandler to Lead NeuroStilbene for Chronic Traumatic Encephalopathy in Football Players
Company to Advance NeuroStilbene Product for High-Performance Athletes
Susceptible to Head Injuries

Wes Chandler and Dr. Santosh Kesari collaborate on CTE Patent after TSOI generates Proof of Concept Data using NeuroStilbene for Prevention of Football - Associated Brain Damage 9/19/18
https://ih.advfn.com/p.php?pid=nmona&article=78289796

60 Minutes article on Combat veterans suffering from CTE as NFL faces its own health crisis 1/7/18
https://www.cbssports.com/nfl/news/60-minutes-combat-veterans-suffering-from-cte-as-nfl-faces-its-own-health-crisis/

60 minutes article on Combat Veterans Coming Home With CTE 9/16/18
https://www.cbsnews.com/news/60-minutes-combat-veterans-coming-home-with-cte-brain-injury/

Pilot pharmacokinetic trial of NanoStilbene for dosage /efficacy
Announced 5/15/18
http://ih.advfn.com/p.php?pid=nmona&article=77431704
Completed 7/2/18
Results :
http://ih.advfn.com/p.php?pid=nmona&article=77784227

A small pilot study is in the planning stages to be performed under the direction of Dr. Santosh Kesari at John Wayne Cancer Institute in Santa Monica CA. by conducting a clinical trial assessing the effects of pterostilbene in modulating immune response and inflammatory parameters in a group of advanced solid tumor cancer patients.
Announced 4/17/18
https://www.sec.gov/Archives/edgar/data/1419051/000107878218000437/f10k123117_10k.htm
Completed 9/25/18
Results :
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143801802

A small pilot study is in the planning stages to be performed under the direction of Dr. Nassir Azimi in San Diego CA. by conducting a study using NanoStilbene in a group of heart attack patients :
http://ih.advfn.com/p.php?pid=nmona&article=78098528

TSOI patent portfolio
http://therapeuticsolutionsint.com/?page_id=68

Share Structure
https://www.otcmarkets.com/stock/TSOI/security
AS - 1.5 B common , 5 M preferred - https://www.nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=LvtIoYTPV6wB1RIovm008A%253d%253d&nt7=0
IO - 931,175,844
Restricted - 816,540,172
Unrestricted - 114,634,972
Held at DTC - 91,991,872
Float - 70,343,547
SEC Filings :https://www.sec.gov/cgi-bin/browse-edgar?company=therapeutic+solutions+international&match=contains&action=getcompany